Skip to main content
Press shift tab to select search category
Loading...
Download the report
A conversation with David Loew
Press shift tab to select search category
X
Loading...
English EN
Français FR
EN
English
EN
Français
FR
Annual Report
< Back
Global
EN
FR
Annual Report
EN
FR
Americas
Asia Pacific
Europe
Middle East & Africa
United States
Brazil
Canada
Mexico
Australia
China
Singapore
South Korea
Japan
Belgium
Ukraine
UK
Germany
France
Nordics
Greece
Italy
Netherlands
Spain
Poland
Russia
Czech Republic
Switzerland
Austria
UAE & Gulf
Study Indication:
Gastroenteropancreatic Neuroendocrine Tumors
68Ga-OPS202 Study for Diagnostic Imaging of GEP NET
Combination of Lanreotide Autogel 120mg and Temozolomide in Progressive GEP-NET
X
You are now leaving the Ipsen group global website. To continue, please click on
Continue
?